 |
|
|
|
|
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Galea E. on NEWS: No Pony in There: Bapi Fails Mild to Moderate ApoE4 Carriers, The finding that immunotherapy against amyloid-β may work in ApoE3 carriers but not in ApoE4... 25 Jul 2012.
|
|
|
 |
|
|
Galea E. on NEWS: Antioxidants No Help for Alzheimer’s, Biomarker Trial Says, I believe that the 19 percent decrease in isoprostane, however small, is very relevant because... 27 Mar 2012.
|
|
|
|
|
|
Galea E. on NEWS: Anti-Amyloid Treatment in Asymptomatic AD Trial, If one defines "AD prevention" broadly, then there already has been a
recent prevention trial... 9 Jan 2012.
|
|
|
|
|
|
Galea E. on PAPER: Sperling RA. et al., 2011, I think that there is consensus about moving preclinical, but we should globally agree on the... 12 Dec 2011.
|
|
|
|
|
|
Galea E. on LIVE DISCUSSION: Reimagining Alzheimer's Disease—Time for Bright New Ideas?
, I agree with Dr. Herrup that Alzheimer’s disease pathogenesis should be examined in the context... 25 Apr 2011.
|
|
|
|
|
|
Galea E. on NEWS: Miami: Is Human Amyloid Imaging Ready for Clinical Trials?, If we accept that the pathological accumulation of amyloid-β in the brain precedes dementia for... 14 Mar 2011.
|
|
|
|
|
|
Galea E. on NEWS: Research Brief—Flurizan Fails Final Hurdle, Company Discontinues Drug, I think that a most plausible explanation for the failure of flurbiprofen in the clinical trial... 28 Jul 2008.
|
|
|
|
|
|
Galea E. on NEWS: PPARγ Partner PGC-1α Linked to Huntington Disease-Like Symptoms, The excellent study by Spiegelman and colleagues shows that the absence of PGC-1 α, a... 4 Oct 2004.
|
|
|
|
|
|
Galea E. on NEWS: More on TGF-β—Can It Protect against AD?, Regarding the paradoxical actions of TGFβ in brain, where the factor appears to be either... 2 Jan 2004.
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
